A sensitivity analysis, in which a gout diagnosis was conducted using an ICD-9-CM or ICD-10-CM code with gout-related medication, showed a lower risk of gout incidence by 15% for SGLT2 inhibitor use. This evidence concerns the gene SLC5A2 and gout.